​

McKesson (MCK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MCK Stock Forecast

McKesson (MCK) stock forecast, based on 31 Wall Street analysts, predicts a 12-month average price target of $994.14, with a high of $1,085.00 and a low of $920.00. This represents a 14.62% increase from the last price of $867.34.

$450 $580 $710 $840 $970 $1 High: $1085 Avg: $994.14 Low: $920 Last Closed Price: $867.34

MCK Stock Rating

McKesson stock's rating consensus is Buy, based on 31 Wall Street analysts. The breakdown includes 1 Strong Buy (3.23%), 24 Buy (77.42%), 6 Hold (19.35%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 31 6 24 1 Strong Sell Sell Hold Buy Strong Buy

MCK Price Target Upside V Benchmarks

TypeNameUpside
StockMcKesson14.62%
SectorHealthcare Stocks 15.45%
IndustryMedical Distribution Stocks17.70%

Price Target Trends

1M3M12M
# Anlaysts-411
Avg Price Target-$1.02K$941.55
Last Closing Price$867.34$867.34$867.34
Upside/Downside-17.34%8.56%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 263104--17
Mar, 263103-117
Feb, 263103-117
Jan, 263103-117
Dec, 252103-116
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 05, 2026Raymond James$970.00$930.314.27%11.84%
Mar 05, 2026Michael ChernyLeerink Partners$1.08K$930.2216.64%25.10%
Feb 18, 2026Barclays$1.05K$946.4710.94%21.06%
Jan 29, 2026Morgan Stanley$966.00$826.6216.86%11.38%
Jan 14, 2026Eric ColdwellRobert W. Baird$968.00$833.3616.16%11.61%
Dec 08, 2025Barclays$960.00$797.9320.31%10.68%
Nov 06, 2025Evercore ISI$1.00K$852.0217.37%15.30%
Oct 27, 2025Kevin CaliendoUBS$920.00$801.3014.81%6.07%
Oct 13, 2025Jefferies$900.00$769.4916.96%3.77%
Aug 13, 2025Stephen BaxterWells Fargo$772.00$659.0117.15%-10.99%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 05, 2026Bank of America SecuritiesBuyBuyhold
Mar 05, 2026Leerink PartnersOutperformOutperformhold
Mar 05, 2026Evercore ISIOutperformOutperformhold
Feb 18, 2026BarclaysOverweightOverweighthold
Feb 05, 2026Cowen & Co.BuyBuyhold
Jan 29, 2026Morgan StanleyOverweightOverweighthold
Dec 22, 2025Cowen & Co.BuyBuyhold
Dec 10, 2025Deutsche BankBuyBuyhold
Dec 08, 2025BarclaysPositiveOverweightinitialise
Nov 06, 2025Evercore ISIOutperformOutperformhold

Financial Forecast

EPS Forecast

$5 $16 $27 $38 $49 $60 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$7.31$25.23$22.54-----
Avg Forecast$23.89$25.96$27.61$32.69$36.82$41.28$46.94$53.78
High Forecast$24.51$26.88$27.95$32.97$37.67$43.85$48.61$55.70
Low Forecast$23.20$25.16$27.47$32.40$35.56$35.30$45.51$52.14
Surprise %-69.40%-2.81%-18.36%-----

Revenue Forecast

$250B $310B $370B $430B $490B $550B Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$263.97B$276.71B$308.95B-----
Avg Forecast$260.88B$275.91B$311.92B$360.18B$396.03B$424.30B$464.80B$517.85B
High Forecast$266.13B$283.48B$312.88B$362.60B$412.08B$425.21B$477.55B$532.05B
Low Forecast$255.12B$269.43B$309.58B$357.80B$382.12B$423.39B$453.88B$505.68B
Surprise %1.18%0.29%-0.95%-----

Net Income Forecast

$500M $2B $3B $5B $6B $8B Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$1.11B$3.56B$3.00B-----
Avg Forecast$1.15B$3.48B$3.00B$4.38B$4.91B$5.31B$6.29B$7.21B
High Forecast$1.39B$3.60B$3.60B$4.42B$5.05B$5.88B$6.52B$7.47B
Low Forecast$919.44M$3.37B$2.39B$4.34B$4.77B$4.73B$6.10B$6.99B
Surprise %-3.33%2.28%0.13%-----

MCK Forecast FAQ

Is McKesson stock a buy?

McKesson stock has a consensus rating of Buy, based on 31 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 24 Buy, 6 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that McKesson is a favorable investment for most analysts.

What is McKesson's price target?

McKesson's price target, set by 31 Wall Street analysts, averages $994.14 over the next 12 months. The price target range spans from $920 at the low end to $1.08K at the high end, suggesting a potential 14.62% change from the previous closing price of $867.34.

How does McKesson stock forecast compare to its benchmarks?

McKesson's stock forecast shows a 14.62% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical distribution stocks industry (17.70%).

What is the breakdown of analyst ratings for McKesson over the past three months?

  • April 2026: 17.65% Strong Buy, 58.82% Buy, 23.53% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 17.65% Strong Buy, 58.82% Buy, 17.65% Hold, 0% Sell, 5.88% Strong Sell.
  • February 2026: 17.65% Strong Buy, 58.82% Buy, 17.65% Hold, 0% Sell, 5.88% Strong Sell.

What is McKesson’s EPS forecast?

McKesson's average annual EPS forecast for its fiscal year ending in March 2025 is $32.69, marking a 45.03% increase from the reported $22.54 in 2024. Estimates for the following years are $36.82 in 2026, $41.28 in 2027, $46.94 in 2028, and $53.78 in 2029.

What is McKesson’s revenue forecast?

McKesson's average annual revenue forecast for its fiscal year ending in March 2025 is $360.18B, reflecting a 16.58% increase from the reported $308.95B in 2024. The forecast for 2026 is $396.03B, followed by $424.3B for 2027, $464.8B for 2028, and $517.85B for 2029.

What is McKesson’s net income forecast?

McKesson's net income forecast for the fiscal year ending in March 2025 stands at $4.38B, representing an 45.98% increase from the reported $3B in 2024. Projections indicate $4.91B in 2026, $5.31B in 2027, $6.29B in 2028, and $7.21B in 2029.